1,301 results on '"Behr, Jürgen"'
Search Results
2. Early mortality in German patients with lung cancer: risk factors associated with 30-and 60-day mortality
3. Interstitielle Lungenerkrankungen und andere progressive pulmonale Fibrosen: Leitlinien-Update zu Diagnostik und Therapie
4. Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies
5. Tumor seeding following CT- guided transthoracic needle biopsy in lung cancer. A case report
6. High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study
7. FK506-Binding Protein 11 Is a Novel Plasma Cell-Specific Antibody Folding Catalyst with Increased Expression in Idiopathic Pulmonary Fibrosis
8. Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
9. Gender-specific differences in COPD symptoms and their impact for the diagnosis of cardiac comorbidities
10. Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis
11. Midregional Proatrial Natriuretic Peptide (MRproANP) is associated with vertebral fractures and low bone density in patients with chronic obstructive pulmonary disease (COPD)
12. Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy
13. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
14. Effects of triple therapy on disease burden in patients of GOLD groups C and D: results from the observational COPD cohort COSYCONET
15. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
16. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
17. Praxisrelevante Entwicklungen in der Lungenheilkunde
18. Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
19. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World.
20. Idiopathische Lungenfibrose
21. Breathing-induced stretch enhances the efficacy of an inhaled and orally delivered anti-fibrosis drug in vitro
22. Proteomics reveals antiviral host response and NETosis during acute COVID-19 in high-risk patients
23. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis.
24. A Systematically Derived Exposure Assessment Instrument for Chronic Hypersensitivity Pneumonitis
25. Epidemiologie und Register bei seltenen Lungenerkrankungen
26. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
27. Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission
28. A new approach for the detection of obesity-related airway obstruction in lung-healthy individuals
29. Overall Response to Anti-IL-5/Anti-IL5-Rα Treatment in Severe Asthma Does Not Depend on Initial Bronchodilator Responsiveness
30. Association of coronary artery calcification with clinical and physiological characteristics in patients with COPD: Results from COSYCONET
31. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency
32. Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial
33. Sex-specific associations of comorbidome and pulmorbidome with mortality in chronic obstructive pulmonary disease: results from COSYCONET
34. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment
35. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity
36. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
37. Response to high-altitude triggers in seasonal asthmatics on and off inhaled corticosteroid treatment
38. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
39. The Role of Thoracic Surgery in Small Cell Lung Cancer – A Large Longitudinal Analysis (2002-2015) Based on Real-World Data
40. A randomized controlled trial of liposomal cyclosporine A for inhalation in the prevention of bronchiolitis obliterans syndrome following lung transplantation
41. Lung Transplantation for Patients With COVID-19
42. Multicenter Standardization of Phase‐Resolved Functional Lung MRI in Patients With Suspected Chronic Thromboembolic Pulmonary Hypertension.
43. Polyomavirus exerts detrimental effects on renal function in patients after lung transplantation
44. Automated quantitative thin slice volumetric low dose CT analysis predicts disease severity in COVID-19 patients
45. Autoren
46. Interstitielle Lungenerkrankungen
47. Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis
48. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
49. To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease
50. Diagnose Algorithmus der pulmonalen Hypertonie und Screening-Verfahren
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.